Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

Clinical trial NCT00458276 · TERMINATED

Trial details

NCT number: NCT00458276
Sponsor: Idorsia Pharmaceuticals Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Diseases Hypertension, Pulmonary

Start date: 2007-04-01
Primary completion: 2008-02-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.